Product Information
ROXICODONE 15 MG TABLET is a brand product labeled by SpecGx LLC, priced at $5.4680 per EA under NDC 23635058110. Its NADAC has been published 268 times since Dec 18, 2013.
FDA first approved this application on Aug 31, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
SpecGx LLCNDC
23635058110
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OXYCODONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021011FDA Approved
8/31/2000
TE Code
AB
On Market Since
8/31/2000
Pharmacological Classes
Price Statistics
The NADAC for ROXICODONE 15 MG TABLET has been published 268 times since Dec 18, 2013, and over the history we have for it it has risen 91.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.4680 per EA |
|---|---|
| All-time high | $5.4821 (Jul 15, 2026) |
| All-time low | $2.8503 (Dec 18, 2013) |
| 52-week high | $5.4821 |
| 52-week low | $5.4680 |
| Median price | $4.6544 |
| Average price | $4.6676 |
| Largest weekly change | +35.0% (Apr 23, 2014) |
| Weeks tracked | 268 |
| Tracking since | Dec 18, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
SpecGx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
oxycodone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROXICODONE 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROXICODONE 15 MG TABLET, manufactured by SpecGx LLC, is $5.4680 per EA (NDC 23635058110), effective Sep 30, 2026.
How has the price of ROXICODONE 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROXICODONE 15 MG TABLET has risen 91.8%. It has been tracked across 268 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for ROXICODONE 15 MG TABLET?
Since Dec 18, 2013, the NADAC for ROXICODONE 15 MG TABLET has ranged from a low of $2.8503 (Dec 18, 2013) to a high of $5.4821 (Jul 15, 2026), with a median of $4.6544 per EA.
Are there cheaper alternatives to ROXICODONE 15 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE HCL (IR) 15 MG TAB, is $0.1966 per EA — about 96% below ROXICODONE 15 MG TABLET.
Who manufactures ROXICODONE 15 MG TABLET?
ROXICODONE 15 MG TABLET (NDC 23635058110) is labeled by SpecGx LLC, and CMS classifies it as a brand product.